RECORDATI RARE DISEASES
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- 251
- Market Cap
- -
Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
16
Drug Approvals
Pasireotide Pamoate Microspheres for Injection
- Product Name
- 注射用双羟萘酸帕瑞肽微球
- Approval Number
- 国药准字HJ20250049
- Approval Date
- Apr 22, 2025
Pasireotide Pamoate Microspheres for Injection
- Product Name
- 注射用双羟萘酸帕瑞肽微球
- Approval Number
- 国药准字HJ20250050
- Approval Date
- Apr 22, 2025
Pasireotide Pamoate Microspheres for Injection
- Product Name
- 注射用双羟萘酸帕瑞肽微球
- Approval Number
- 国药准字HJ20250048
- Approval Date
- Apr 22, 2025
Osilodrostat Phosphate Tablets
- Product Name
- 适锐飒
- Approval Number
- 国药准字HJ20240101
- Approval Date
- Sep 19, 2024
Carglumic Acid Dispersible Tablets
- Product Name
- 卡谷氨酸分散片
- Approval Number
- 国药准字HJ20230085
- Approval Date
- Jun 27, 2023
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Cold Agglutinin Disease Real World Evidence Registry
- Conditions
- Cold Agglutinin Disease (CAD)Cold Agglutinin Syndrome (CAS)
- Interventions
- First Posted Date
- 2023-03-30
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Recordati Rare Diseases
- Target Recruit Count
- 400
- Registration Number
- NCT05791708
- Locations
- 🇺🇸
University of Alabama at Birmingham Site Number : 1230, Birmingham, Alabama, United States
🇺🇸SLO Oncology and Hematology Site Number : 1235, San Luis Obispo, California, United States
🇺🇸Mission Hope Medical Oncology Site Number : 1241, Santa Maria, California, United States
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
- Conditions
- HyperammonemiaMethylmalonic AcidemiaPropionic Acidemia
- Interventions
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Recordati Rare Diseases
- Target Recruit Count
- 20
- Registration Number
- NCT05040178
- Locations
- 🇺🇸
Children's National Hospital, Washington, District of Columbia, United States
🇺🇸University of South Florida, Tampa, Florida, United States
🇺🇸Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Recordati Rare Diseases
- Target Recruit Count
- 108
- Registration Number
- NCT04276558
- Locations
- 🇺🇸
Nature Coast Clinical Research, Crystal River, Florida, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸University of Maryland School of Medicine UMSOM, Baltimore, Maryland, United States
Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Recordati Rare Diseases
- Target Recruit Count
- 95
- Registration Number
- NCT04176523
- Locations
- 🇫🇷
Hopital Des Enfants, CHU de Bordeaux-GH Pellegrin, Bordeaux, France
🇫🇷Hopital de la Conception, Marseille, France
🇫🇷Hôpital de la Timone, Marseille, France
Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)
- First Posted Date
- 2019-10-14
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Recordati Rare Diseases
- Target Recruit Count
- 5
- Registration Number
- NCT04125927
- Locations
- 🇧🇪
UZ Leuven, Leuven, Belgium
🇫🇷Hôpital Necker-Enfants Malades, Paris, France
🇩🇪Klinik für Pädiatrische Nieren, Hannover, Germany